Exchange Traded Concepts, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Exchange Traded Concepts, LLC

  • $4.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023
BUY
$0.5 - $0.72 $5,781 - $8,324
11,562 Added 161.23%
18,733 $10,000
Q3 2022

Oct 07, 2022
BUY
$0.87 - $1.36 $885 - $1,384
1,018 Added 16.54%
7,171 $5,000
Q2 2022

Jul 20, 2022
BUY
$0.86 - $2.06 $4,149 - $9,939
4,825 Added 363.33%
6,153 $7,000
Q1 2022

Apr 26, 2022
BUY
$1.83 - $3.02 $2,430 - $4,010
1,328 New
1,328 $3,000

Others Institutions Holding ZYNE

# of Institutions
4
Shares Held
774K
Call Options Held
0
Put Options Held
0
View Full List

About Zynerba Pharmaceuticals, Inc.

ZYNE Quotes by TradingView
  • Ticker ZYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,753,100
  • Description
  • Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...
More about ZYNE
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email